The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT03487913 · COMPLETED
Trial details
- NCT number
- NCT03487913
- Sponsor
- Palladio Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2019-12-02
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.